Guardant Health, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 301.7M | 281.3M | 265.2M | 232.1M | 203.5M | 201.8M | 191.5M | 177.2M |
| Cost of Goods Sold | 104.9M | 99.5M | 93.6M | 81.2M | 74.7M | 77.6M | 74.5M | 72.4M |
| Gross Profit | 196.7M | 181.8M | 171.6M | 150.9M | 128.7M | 124.2M | 117.0M | 104.8M |
| R&D Expenses | 91.0M | 98.3M | 90.0M | 87.4M | 88.5M | 93.5M | 87.3M | 83.1M |
| Operating Expenses | 318.1M | 302.6M | 270.6M | 257.3M | 239.8M | 250.2M | 234.3M | 205.4M |
| Operating Income | -121.3M | -120.8M | -99.0M | -106.4M | -111.0M | -126.0M | -117.3M | -100.6M |
| Other Income / Gains | 9.6M | -9.4M | 6.4M | 6.6M | 16.2M | 15.7M | 9.6M | -1.9M |
| Net Income | -112.1M | -128.5M | -92.7M | -99.9M | -95.2M | -111.0M | -107.8M | -102.6M |
| EPS (Diluted) | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.652 | 0.646 | 0.647 | 0.65 | 0.633 | 0.616 | 0.611 | 0.591 |
| General And Administrative Expenses | 57.9M | 60.9M | 53.3M | 50.3M | 47.0M | 51.9M | 49.1M | 40.5M |
| Selling And Marketing Expenses | 169.1M | 143.4M | 127.4M | 119.6M | 104.3M | 104.8M | 97.9M | 81.9M |
| Selling General And Administrative Expenses | 227.1M | 204.3M | 180.6M | 169.8M | 151.3M | 156.6M | 147.0M | 122.3M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 423.0M | 402.1M | 364.2M | 338.5M | 314.5M | 327.8M | 308.8M | 277.9M |
| Interest Income | 11.2M | 10.0M | 7.4M | 7.6M | 9.1M | 11.7M | 13.3M | 13.9M |
| Interest Expense | 1.3M | 1.2M | 943K | 983K | 791K | 645K | 646K | 645K |
| Depreciation And Amortization | 9.4M | 10.1M | 9.4M | 10.0M | 10.2M | 10.5M | 10.6M | 10.7M |
| Ebitda | -100.9M | -119.0M | -82.2M | -88.8M | -83.8M | -99.2M | -96.5M | -91.2M |
| Ebitdaratio | -0.335 | -0.423 | -0.31 | -0.383 | -0.412 | -0.491 | -0.504 | -0.514 |
| Operating Income Ratio | -0.402 | -0.43 | -0.373 | -0.459 | -0.546 | -0.624 | -0.613 | -0.568 |
| Income Before Tax | -111.7M | -130.2M | -92.6M | -99.9M | -94.9M | -110.3M | -107.7M | -102.5M |
| Income Before Tax Ratio | -0.37 | -0.463 | -0.349 | -0.43 | -0.466 | -0.546 | -0.563 | -0.578 |
| Income Tax Expense | 372K | -1.7M | 136K | 38K | 290K | 716K | 30K | 133K |
| Net Income Ratio | -0.372 | -0.457 | -0.35 | -0.43 | -0.468 | -0.55 | -0.563 | -0.579 |
| Epsdiluted | -0.85 | -1.00 | -0.74 | -0.80 | -0.77 | -0.90 | -0.88 | -0.84 |
| Weighted Average Shs Out | 131.3M | 128.7M | 124.8M | 124.1M | 123.9M | 123.8M | 123.1M | 122.4M |
| Weighted Average Shs Out Dil | 131.3M | 128.7M | 125.3M | 124.1M | 123.9M | 123.8M | 123.1M | 122.4M |